Dr. Reddys Laboratories informs about press release

11 Aug 2020 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 11th August   2020 ‘Dr. Reddy's Laboratories announces the First-to Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1294.65 7.45 (0.58%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×